Skip to content
drillr.ai
Sign up

02566.HK

Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd.

HKSE · Healthcare · Biotechnology · CN

HKD 4.98
−2.64%
Ask drillr

  • Sep 29, 2026, 01:06 UTC

    Jiuyuan Gene (02566.HK) repurchased 1.3824 million of its own shares on September 28 at prices between HK$5.685 and HK$5.83 per share, for about HK$7.9855 million.

    Source:

  • Aug 20, 2026, 02:08 UTC

    Jiyuan Gene announced that its board resolved to continue its H-share buyback plan, repurchasing up to 100 million RMB of H-shares on the open market with its own funds before the buyback mandate expires.

    Source:

  • Aug 20, 2026, 01:08 UTC

    Jiuyuan Gene announced its interim results for the six months ended June 2026, with revenue of RMB 631 million, down 1.2% year-on-year, and net profit of RMB 91.269 million, up 1.2% year-on-year.

    Source: